FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024746677> ?p ?o ?g. }

• W2024746677 endingPage "46D" @default.
• W2024746677 startingPage "40D" @default.
• W2024746677 abstract "Azimilide, a novel class III antiarrhythmic agent, blocks both the slowly activating (IKs) and rapidly activating (IKr) components of the delayed rectifier potassium current, which distinguishes it from conventional potassium channel blockers such as sotalol and dofetilide, which block only IKr. Azimilide is being developed to prolong the time to recurrence of atrial fibrillation, atrial flutter, and paroxysmal supraventricular tachycardia in patients with and without structural heart disease. Azimilide is also being studied for its role in prevention of sudden cardiac death in high-risk patients after myocardial infarction (MI). Preclinical and clinical studies indicate that azimilide prolongs cardiac refractory period in a dose-dependent manner, as manifested by increases in action potential duration, QTc interval, and effective refractory period. Azimilide does not affect PR or QRS interval and minimally affects hemodynamic properties such as blood pressure and heart rate. Its in vivo effects appear to be rate-independent and are maintained under ischemic or hypoxic conditions, properties of potential clinical significance. Azimilide has shown excellent efficacy (>85%) in suppressing supraventricular arrhythmias in a variety of dog models. It also suppressed complex ventricular arrhythmias in infarcted dogs and, in a sudden death cardiac model, decreased mortality. Azimilide pharmacokinetics are very predictable. The drug is completely absorbed, and the extent of absorption is not affected by food. It can be administered once daily. Clinical data suggest that dose adjustments of azimilide are not required for age, gender, hepatic or renal function, or concomitant use of digoxin or warfarin. Azimilide has a good safety profile in open-label safety studies in >800 supraventricular arrhythmia patients, most with structural heart disease. The incidence of serious adverse events, including torsade de pointes, is low. The rate of patient withdrawal from long-term studies is also encouragingly low. Unlike amiodarone, azimilide has shown no evidence of pulmonary or ocular toxicity. Azimilide is expected to provide a unique new therapy for the prevention of supraventricular arrhythmias and sudden cardiac death when Phase III clinical trials are complete and safety and efficacy are confirmed." @default.
• W2024746677 created "2016-06-24" @default.
• W2024746677 creator A5025313011 @default.
• W2024746677 creator A5036316377 @default.
• W2024746677 creator A5042857967 @default.
• W2024746677 creator A5052324532 @default.
• W2024746677 creator A5076450044 @default.
• W2024746677 date "1998-03-01" @default.
• W2024746677 modified "2023-10-14" @default.
• W2024746677 title "Azimilide Dihydrochloride, a Novel Antiarrhythmic Agent" @default.
• W2024746677 cites W1972710335 @default.
• W2024746677 cites W1976951265 @default.
• W2024746677 cites W1983136738 @default.
• W2024746677 cites W2000020891 @default.
• W2024746677 cites W2006531243 @default.
• W2024746677 cites W2006883095 @default.
• W2024746677 cites W2007249629 @default.
• W2024746677 cites W2013603594 @default.
• W2024746677 cites W2076862565 @default.
• W2024746677 cites W2080005454 @default.
• W2024746677 cites W2099086672 @default.
• W2024746677 cites W2111636093 @default.
• W2024746677 cites W2331920186 @default.
• W2024746677 doi "https://doi.org/10.1016/s0002-9149(98)00152-0" @default.
• W2024746677 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9537222" @default.
• W2024746677 hasPublicationYear "1998" @default.
• W2024746677 type Work @default.
• W2024746677 sameAs 2024746677 @default.
• W2024746677 citedByCount "67" @default.
• W2024746677 countsByYear W20247466772013 @default.
• W2024746677 countsByYear W20247466772016 @default.
• W2024746677 countsByYear W20247466772017 @default.
• W2024746677 countsByYear W20247466772019 @default.
• W2024746677 countsByYear W20247466772021 @default.
• W2024746677 crossrefType "journal-article" @default.
• W2024746677 hasAuthorship W2024746677A5025313011 @default.
• W2024746677 hasAuthorship W2024746677A5036316377 @default.
• W2024746677 hasAuthorship W2024746677A5042857967 @default.
• W2024746677 hasAuthorship W2024746677A5052324532 @default.
• W2024746677 hasAuthorship W2024746677A5076450044 @default.
• W2024746677 hasConcept C118441451 @default.
• W2024746677 hasConcept C126322002 @default.
• W2024746677 hasConcept C164705383 @default.
• W2024746677 hasConcept C189327125 @default.
• W2024746677 hasConcept C2775935837 @default.
• W2024746677 hasConcept C2777796741 @default.
• W2024746677 hasConcept C2778131192 @default.
• W2024746677 hasConcept C2779161974 @default.
• W2024746677 hasConcept C2780074459 @default.
• W2024746677 hasConcept C2780486423 @default.
• W2024746677 hasConcept C2781005686 @default.
• W2024746677 hasConcept C42219234 @default.
• W2024746677 hasConcept C500558357 @default.
• W2024746677 hasConcept C71924100 @default.
• W2024746677 hasConceptScore W2024746677C118441451 @default.
• W2024746677 hasConceptScore W2024746677C126322002 @default.
• W2024746677 hasConceptScore W2024746677C164705383 @default.
• W2024746677 hasConceptScore W2024746677C189327125 @default.
• W2024746677 hasConceptScore W2024746677C2775935837 @default.
• W2024746677 hasConceptScore W2024746677C2777796741 @default.
• W2024746677 hasConceptScore W2024746677C2778131192 @default.
• W2024746677 hasConceptScore W2024746677C2779161974 @default.
• W2024746677 hasConceptScore W2024746677C2780074459 @default.
• W2024746677 hasConceptScore W2024746677C2780486423 @default.
• W2024746677 hasConceptScore W2024746677C2781005686 @default.
• W2024746677 hasConceptScore W2024746677C42219234 @default.
• W2024746677 hasConceptScore W2024746677C500558357 @default.
• W2024746677 hasConceptScore W2024746677C71924100 @default.
• W2024746677 hasIssue "6" @default.
• W2024746677 hasLocation W20247466771 @default.
• W2024746677 hasLocation W20247466772 @default.
• W2024746677 hasOpenAccess W2024746677 @default.
• W2024746677 hasPrimaryLocation W20247466771 @default.
• W2024746677 hasRelatedWork W1530248218 @default.
• W2024746677 hasRelatedWork W1985052140 @default.
• W2024746677 hasRelatedWork W1999852848 @default.
• W2024746677 hasRelatedWork W2037177265 @default.
• W2024746677 hasRelatedWork W2052649904 @default.
• W2024746677 hasRelatedWork W2084976516 @default.
• W2024746677 hasRelatedWork W2087234566 @default.
• W2024746677 hasRelatedWork W2093869205 @default.
• W2024746677 hasRelatedWork W2795169638 @default.
• W2024746677 hasRelatedWork W4307172607 @default.
• W2024746677 hasVolume "81" @default.
• W2024746677 isParatext "false" @default.
• W2024746677 isRetracted "false" @default.
• W2024746677 magId "2024746677" @default.
• W2024746677 workType "article" @default.